Document is current
Any future updates will be listed below
-
Authors
Hahn, Dongwoo
Quick, Joseph D.
Thompson, Brian R.
Crabtree, Adelyn
Hackel, Benjamin J.
Bates, Frank S.
Metzger, Joseph M.
-
Funding
Funding for this research was provided by:
National Institute of Arthritis and Musculoskeletal and Skin Diseases (5R01AR071349-05, 5R01AR071349-05, 5R01AR071349-05, 5R01AR071349-05, 5R01AR071349-05, 5R01AR071349-05, 5R01AR071349-05)
National Heart, Lung, and Blood Institute (5R01HL138490-04, 5R01HL138490-04, 5R01HL138490-04, 5R01HL138490-04, 5R01HL138490-04, 5R01HL138490-04, 5R01HL138490-04)
- License Information
-
More Information
Article History
Received: 8 December 2022
Accepted: 5 May 2023
First Online: 19 May 2023
Declarations
:
: The protocol used in this study was approved by the Institutional Animal Care and Use Committee of the University of Minnesota. We followed guidelines set by the National Institute of Health for all animal procedures performed in this study.
: J.M.M. is on the scientific advisory board of and holds shares in Phrixus Pharmaceuticals Inc., a company developing novel therapeutics for heart failure. The terms of this arrangement have been reviewed and approved by the University of Minnesota in accordance with its conflict of interest policies.
